COVID-19 Vaccine Protects Against the Corona Virus in Patients with Celiac Disease

The first-of-its-kind study was conducted in Israel by KSM - Maccabi's Research and Innovation Center. The results were published in the peer-reviewed journal Viruses.

Related Keywords

New York ,United States ,Israel ,Benjamin Lebwohl ,Dvir Assouline ,Amir Ben Tov ,Maccabi Research ,Maccabi Healthcare Services ,Innovation Center ,Pfizer ,Celiac Disease ,Tal Patalon ,Celiac Disease Center ,Columbia University Irving Medical Center , ,